Shares of Guided Therapeutics Inc. (OTCMKTS:GTHP – Get Free Report) were up 0.8% on Monday . The company traded as high as $0.2319 and last traded at $0.2319. 2,323 shares traded hands during trading, a decline of 77% from the average session volume of 9,941 shares. The stock had previously closed at $0.23.
Guided Therapeutics Stock Up 11.4%
The business has a fifty day moving average price of $0.26 and a 200 day moving average price of $0.24. The company has a market capitalization of $23.65 million, a P/E ratio of -6.12 and a beta of 0.69.
Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) last released its earnings results on Thursday, August 13th. The company reported ($0.01) EPS for the quarter.
About Guided Therapeutics
Guided Therapeutics, Inc is a medical technology company focused on developing diagnostic products for the detection of cancer and precancerous conditions. Its technology is based on biophotonic tissue analysis, which uses light to identify changes in tissue that may be associated with disease.
The company’s principal product is LuViva Advanced Cervical Scan, a noninvasive diagnostic device designed to evaluate cervical tissue for abnormalities associated with cervical cancer and precancer.
Recommended Stories
- Five stocks we like better than Guided Therapeutics
- Chips to Bots: Qualcomm’s Agentic AI Breakout
- Ciena Fell 40%—Now One Analyst Sees 50% Upside
- Energy Transfer Taps the AI Power Boom
- Viking’s Obesity Edge May Be Staying Power, Not Weight Loss
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
